Multianalyte quantification of vitamin B6 and B2 species in the nanomolar range in human plasma by liquid chromatography-tandem mass spectrometry

Clinical Chemistry

Volumn 51, Issue 7, 2005, Pages 1206-1216

  Midttun, Øivind ^a   Hustad, Steinar ^a   Solheim, Einar ^a   Schneede, Jørn ^a   Ueland, Per M ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETONITRILE; BLOOD EXTRACT; BUFFER; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; PLACEBO; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE; PYRIDOXAMINE PHOSPHATE; PYRIDOXAMINE PHOSPHATE OXIDASE; PYRIDOXIC ACID; PYRIDOXINE; RIBOFLAVIN; TRICHLOROACETIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRECIPITATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; STANDARD; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; ADOLESCENT; BLOOD; MASS SPECTROMETRY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHILD; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; RIBOFLAVIN; SENSITIVITY AND SPECIFICITY; VITAMIN B 6;

EID: 23444447854     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.051169     Document Type: Article

References (70)

1. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228-37.
2. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-32.
3. Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000;46:1065-71.
4. Hustad S, Nedrebø BG, Ueland PM, Schneede J, Vollset SE, Ulvik A, et al. Phenotypic expression of the methylenetetrahydrofolate reductase 677C>T polymorphism and flavin cofactor availability in thyroid dysfuction. Am J Clin Nutr 2004;80:1050-7.
5. 6 status indices and associated confounders, in young people aged 4-18 years and in people aged 65 years and over, in two national British surveys. Public Health Nutr 1999;2:529-35.
6. Bates CJ. Vitamin analysis. Ann Clin Biochem 1997;34:599-626.
7. 6. In: Maurice E, Olson JA, Shike M, eds. Modern nutrition in health and disease, 8th ed. Philadelphia: Lea & Febiger, 1994:383-94.
8. 6. Int J Vitam Nutr Res 1993;63:278-82.
9. Bates CJ, Pentieva KD, Matthews N, Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 1999;280:101-11.
10. Bates CJ, Pentieva KD, Prentice A, Mansoor MA, Finch S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br J Nutr 1999;81:191-201.
11. Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr 2003;77:1352-60.
12. Hustad S, McKinley MC, McNulty H, Schneede J, Strain JJ, Scott JM, et al. Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin Chem 2002;48: 1571-7.
13. 6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998;97: 437-43.
14. 6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke 2003;34:e51-4.
15. Boisvert WA, Castañeda C, Mendoza I, Langeloh G, Solomons NW, Gershoff SN, et al. Prevalence of riboflavin deficiency among Guatemalan elderly people and its relationship to milk intake. Am J Clin Nutr 1993;58:85-90.
16. Benton D, Haller J, Fordy J. The vitamin status of young British adults. Int J Vitam Nutr Res 1997;67:34-40.
17. Madigan SM, Tracey F, McNulty H, Eaton-Evans J, Coulter J, McCartney H, et al. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people. Am J Clin Nutr 1998;68:389-95.
18. 6 vitamers and pyridoxic acid in plasma: development and evaluation of a high-performance liquid chromatographic assay. Anal Biochem 2002;305:82-9.
19. 6 in biological samples. Anal Biochem 1983;129:310-7.
20. Deitrick CL, Katholi RE, Huddleston DJ, Hardiek K, Burrus L. Clinical adaptation of a high-performance liquid chromatographic method for the assay of pyridoxal 5′-phosphate in human plasma. J Chromatogr B Biomed Sci Appl 2001;751:383-7.
21. 6 compounds in plasma. Clin Chem 1989;35:241-5.
22. 6 vitamers, especially pyridoxal 5′-phosphate. J Chromatogr A 1996;722:295-301.
23. 6 vitamers in serum by simple isocratic high performance liquid chromatography. J Liquid Chromatogr 1990;13:191-201.
24. 6 in human serum. J Liquid Chromatogr 1992;15:897-914.
25. 6 vitamers and pyridoxic acid in plasma, tissues and urine using high performance liquid chromatography. Nutr Res 1989;9:259-72.
26. 6 vitamers and pyridoxic acid in biological samples. J Chromatogr 1992; 578:45-51.
27. Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, O'Reilly DS. Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed Life Sci 2003;792:333-43.
28. 6 vitamer and 4-pyridoxic acid concentrations of men fed controlled diets. J Chromatogr 1988; 428:35-42.
29. Rybak ME, Pfeiffer CM. Clinical analysis of vitamin B(6): determination of pyridoxal 5′-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal Biochem 2004;333: 336-44.
30. Miller JW, Selhub J, Nadeau MR, Thomas CA, Feldman RG, Wolf PA. Effect of L-DOPA on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology 2003;60:1125-9.
31. Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R. Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 2003;114:283-7.
32. Sassi S, Cosmi B, Palareti G, Legnani C, Grossi G, Musolesi S, et al. Influence of age, sex and vitamin status on fasting and post-methionine load plasma homocysteine levels. Haematologica 2002;87:957-64.
33. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. J Nutr 1996;126:1258S-65S.
34. de Bree A, Verschuren WM, Blom HJ, Nadeau M, Trijbels FJ, Kromhout D. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis 2003; 166:369-77.
35. Chan SJ, Chang CN, Hsu JC, Lee YS, Shen CH. Homocysteine, vitamin B(6), and lipid in cardiovascular disease. Nutrition 2002; 18:595-8.
36. 6 treatment: a randomized placebo-controlled study. Clin Chem 2003;49:155-61.
37. Baker H, Frank O. Analysis of riboflavin and its derivatives in biological fluids and tissues. In: Rivlin RS, ed. Riboflavin. New York: Plenum Press, 1975:49-79.
38. Nielsen P. Flavins. In: De Leenheer AP, Lambert WE, Nelis HJ, eds. Modern chromatographic analysis of vitamins, 3rd ed. New York: Marcel Dekker, 2000:391-433.
39. Capo-chichi CD, Guéant JL, Feillet F, Namour F, Vidailhet M. Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2000;739:219-24.
40. Hustad S, Ueland PM, Schneede J. Quantification of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma by capillary electrophoresis and laser-induced fluorescence detection. Clin Chem 1999;45:862-8.
41. Floridi A, Palmerini CA, Fini C, Pupita M, Fidanza F. High performance liquid chromatographic analysis of flavin adenine dinucleotide in whole blood. Int J Vitam Nutr Res 1985;55:187-91.
42. 6-vitamers in serum and whole blood. Int J Vitam Nutr Res 1987;57:273-8.
43. Ohkawa H. A simple method for micro-determination of flavins in human serum and whole blood by high-performance liquid chromatography. Biochem Int 1982;4:187-94.
44. 2 vitamer flavin adenine dinucleotide in whole blood by high-performance liquid chromatography with fluorometric detection. J Chromatogr 1982;228:311-6.
45. Lambert WE, Cammaert PM, de Leenheer AP. Liquid-chromatographic measurement of riboflavin in serum and urine with isoriboflavin as internal standard. Clin Chem 1985;31:1371-3.
46. Pietta P, Calatroni A, Rava A. Hydrolysis of riboflavin nucleotides in plasma monitored by high-performance liquid chromatography. J Chromatogr 1982;229:445-9.
47. Lopez-Anaya A, Mayersohn M. Quantification of riboflavin, riboflavin 5′-phosphate and flavin adenine dinucleotide in plasma and urine by high-performance liquid chromatography. J Chromatogr 1987;423:105-13.
48. Zempleni J. Determination of riboflavin and flavocoenzymes in human blood plasma by high-performance liquid chromatography. Ann Nutr Metab 1995;39:224-6.
49. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;75:3019-30.
50. Antignac J-P, de Wasch K, Monteau F, De Brabander H, Andre F, Le Bizec B. The ion suppression phenomenon in liquid chromatography-mass spectrometry and its consequences in the field of residue analysis. Anal Chim Acta 2005;529:129-36.
51. Blanchard J. Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysis. J Chromatogr 1981;226: 455-60.
52. Polson C, Sarkar P, Incledon B, Raguvaran V, Grant R. Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003;785:263-75.
53. Ubbink JB, Serfontein WJ, de Villiers LS. Analytical recovery of protein-bound pyridoxal-5′-phosphate in plasma analysis. J Chromatogr 1986;375:399-404.
54. Lumeng L, Brashear RE, Li T-K. Pyridoxal 5′-phosphate in plasma: source, protein-binding, and cellular transport. J Lab Clin Med 1974;84:334-43.
55. New AP, Wolff JC, Crabtree S, Freitas do Santos L, Okafo G, Lee J, et al. Preliminary investigation of the application of on-line membrane extraction of trifluoroacetic acid as an aid to improvement of negative ion electrospray mass spectrometry data. J Chromatogr A 2001;913:205-8.
56. Dunphy R, Burinsky DJ. Detection of choline and acetylcholine in a pharmaceutical preparation using high-performance liquid chromatography/ electrospray ionization mass spectrometry. J Pharm Biomed Anal 2003;31:905-15.
57. 6: different forms of the vitamin, its metabolites, antimetabolites, and analogs. Org Mass Spectrom 1968;1:151-66.
58. Abian J, Susin S, Abadia J, Gelpi E. Thermospray and electrospray mass spectrometry of flavocoenzymes. Analysis of riboflavin sulphates from sugar beef. Anal Chim Acta 1995;302:215-23.
59. Fu I, Woolf EJ, Matuszewski BK. Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection. J Pharm Biomed Anal 1998;18:347-57.
60. Alder LL, S. Lindtner K. Stan H-J. The ECHO technique-the more effective way of data evaluation in liquid chromatography-tandem mass spectrometry analysis. J Chromatogr A 2004;1058:67-79.
61. Zrostliková JH, Poustka J, Begany P. Alternative calibration approaches to compensate the effect of co-extracted matrix components in liquid chromatography-electrospray ionisation tandem mass spectrometry analysis of pesticide residues in plant materials. J Chromatogr A 2002;973:13-26.
62. Niessen WM. State-of-the-art in liquid chromatography-mass spectrometry. J Chromatogr A 1999;856:179-97.
63. 6 metabolism in man. Clin Chim Acta 1990;190:67-80.
64. 6-related compounds. J Chromatogr A 1997;790:83-91.
65. 6 standard solutions. Clin Chim Acta 1986;160:307-12.
66. 6 to laboratory light conditions. J Assoc Off Anal Chem 1979;62:1170-3.
67. 6 degradation. J Agric Food Chem 1983;31:876-80.
68. 6 nutritional status. J Chromatogr Biomed Appl 1985;342:277-84.
69. Borschel MW, Kirksey A, Hamaker BR. A micromethod for determination of plasma pyridoxal phosphate and its use in assessment of storage stability of the vitamer. J Pediatr Gastroenterol Nutr 1987;6:409-13.
70. Driskell JA, Giraud DW, Mitmesser SH. Vitamin B-6 intakes and plasma B-6 vitamer concentrations of men and women, 19-50 years of age. Int J Vitam Nutr Res 2000;70:221-5.